- Bliv medlem
-
Du er ikke logget ind
Log ind Opret dig
Du er ikke logget ind
Beskrivelse
Journeys in Myeloma Research: A Compendium of Clinical Breakthroughs provides a thorough exploration of multiple myeloma, driven by the latest scientific advancements showcased at the American Society of Clinical Oncology Symposium 2020. This anthology dives deep into genetic abnormalities, novel therapeutic targets, and their implications at varying stages of the disease. The collection presents illuminating studies such as the CASSIOPEIA, ENDURANCE, and TOURMALINE-MM4 trials, providing critical insights into new treatment regimens. The book emphasizes the genetic undercurrents of myeloma, like chromosome 1q21 abnormalities, Ratio-PA as a prognostic biomarker, and post-translational modifications like ubiquitination. It also explores the intriguing role of GLIPR1 in myeloma pathogenesis and the complex interactions within the myeloma tumor microenvironment. This compendium underscores the transformative potential of targeting PDIA1 and the importance of longitudinal minimal residual disease assessment. Additionally, it highlights the emerging role of immunotherapy in altering the therapeutic landscape. Each article constructs a cohesive framework for understanding and tackling multiple myeloma, making this collection an invaluable resource for clinicians and researchers dedicated to advancing myeloma treatment and care.
Quality Research Publishing is dedicated to making knowledge more accessible to the general public by curating a topical compilation of the latest research on various subjects and providing plain language summaries.
Each of the articles in this book is available individually and digitally without cost. However, we believe it is important for the contextualizing and sharing of educational and scientific work to curate this research in a way that is understandable and helpful to the average person seeking deeper knowledge of a particular subject.
The research articles compiled for this book were published under a permissive Creative Commons license, are in the public domain, or have no copyright restrictions, permitting their use in this book. If you have questions about the licensing of any article, please visit qualityresearchpublishing.com.
